Loading…
Bal Pharma (BALPHARMA)₹83.18+0.80%Pharmaceuticals
Bal Pharma is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 18.6 against a peer median of 14.5, and ROCE of 10.0% against a peer median of 14.0%, and latest-quarter sales growth of 34.5% against a peer median of 14.1%. By market cap it is #6 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Quest Laboratories | 142 | 9.5 | 17.9 | 16.8 | 0.08 | 0.0 | 112 | 15 | −30.3 | 48.2 | vs BALPHARMA |
| Panchsheel Organics | 141 | 13.0 | 10.0 | 7.9 | 0.04 | 3.0 | 107 | 11 | 9.5 | −46.5 | vs BALPHARMA |
| Par Drugs and Chemicals | 139 | 9.6 | 17.0 | 12.4 | 0.00 | 0.0 | 104 | 13 | 20.2 | 41.6 | vs BALPHARMA |
| Speciality Medicines | 136 | 10.4 | 25.0 | 25.5 | 0.09 | 0.0 | 75 | 13 | 45.2 | 166.1 | vs BALPHARMA |
| Parnax Lab | 134 | 15.0 | 14.0 | 14.4 | 0.87 | 0.0 | 249 | 12 | 6.4 | −86.6 | vs BALPHARMA |
| Bal Pharma | 132 | 18.6 | 10.0 | 7.9 | 1.96 | 1.4 | 313 | 6 | 34.5 | 460.0 | — |
| Lactose (India) | 132 | 21.9 | 11.1 | 9.8 | 0.96 | 0.0 | 163 | 6 | 64.9 | 190.8 | vs BALPHARMA |
| Krebs Biochemicals and Industries | 129 | — | −15.0 | — | — | 0.0 | 24 | −17 | 27.4 | — | vs BALPHARMA |
| Asston Pharmaceuticals | 129 | 33.3 | 16.8 | 15.5 | 0.13 | 0.0 | 25 | 4 | 10.8 | −75.8 | vs BALPHARMA |
| BALAXI PHARMACEUTICALS | 125 | 55.3 | 3.0 | 0.6 | 0.23 | 0.0 | 270 | 1 | 14.1 | 336.7 | vs BALPHARMA |
| Parnax Lab | 125 | 14.0 | 14.1 | 14.4 | 0.87 | 0.0 | 249 | 12 | 6.4 | −86.6 | vs BALPHARMA |
| Peer median | 132 | 14.5 | 14.0 | 13.4 | 0.18 | 0.0 | 112 | 11 | 14.1 | 44.9 |
Listed companies closest to Bal Pharma in Pharmaceuticals include Quest Laboratories, Panchsheel Organics, Par Drugs and Chemicals, Speciality Medicines, Parnax Lab, Lactose (India), Krebs Biochemicals and Industries, Asston Pharmaceuticals.
Quest Laboratories, with a market cap of ₹142 Cr.
Bal Pharma trades at a P/E of 18.6; the median of its peer set is 14.5. A P/E above or below the median is a description, not a judgement on value.
Bal Pharma's return on capital employed is 10.0%, below the peer median of 14.0%.